Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Ryder

Showing results (231-240 of 266) with videos related to

Pageof 27
Sort By:
The Lancet. Gastroenterology & Hepatology|February 8, 2024
Top ten research priorities for alcohol use disorder and alcohol-related liver disease: results of a multistakeholder research priority setting partnershipMohsan Subhani, Ashwin Dhanda, Adina Olaru, et al.
Epidemics|June 30, 2019
The contact structure of Great Britain's salmon and trout aquaculture industryA E Jones, L A Munro, D M Green, et al.
Alimentary Pharmacology & Therapeutics|October 2, 2023
In severe alcohol-related hepatitis, acute kidney injury is prevalent, associated with mortality independent of liver disease severity, and can be predicted using IL-8 and micro-RNAsLuke D Tyson, Stephen Atkinson, Robert W Hunter, et al.
Nature Communications|December 8, 2011
A complex multi-notch astronomical filter to suppress the bright infrared skyJ Bland-Hawthorn, S C Ellis, S G Leon-Saval, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 18, 2014
Lack of efficacy of an inhibitor of PDE4 in phase 1 and 2 trials of patients with nonalcoholic steatohepatitisVlad Ratziu, Pierre Bedossa, Sven M Francque, et al.
Frontline Gastroenterology|October 26, 2017
The impact of rifaximin-α on the hospital resource use associated with the management of patients with hepatic encephalopathy: a retrospective observational study (IMPRESS)Mark Hudson, Amr Radwan, Paola Di Maggio, et al.
Alimentary Pharmacology & Therapeutics|April 24, 2014
Review article: 2014 UK consensus guidelines - hepatitis C management and direct-acting anti-viral therapyM H Miller, K Agarwal, A Austin, et al.
Hepatology Communications|May 16, 2018
NI-0801, an anti-chemokine (C-X-C motif) ligand 10 antibody, in patients with primary biliary cholangitis and an incomplete response to ursodeoxycholic acidKathy L de Graaf, Geneviève Lapeyre, Florence Guilhot, et al.
Nature|May 29, 2020
A census of baryons in the Universe from localized fast radio burstsJ-P Macquart, J X Prochaska, M McQuinn, et al.
Hepatology Communications|April 7, 2023
Regulation of immune responses in primary biliary cholangitis: a transcriptomic analysis of peripheral immune cellsVictoria Mulcahy, Evaggelia Liaskou, Jose-Ezequiel Martin, et al.
Pageof 27

Showing results (231-240 of 266) with videos related to

Sort By:
Pageof 27
The Lancet. Gastroenterology & Hepatology|February 8, 2024
Top ten research priorities for alcohol use disorder and alcohol-related liver disease: results of a multistakeholder research priority setting partnershipMohsan Subhani, Ashwin Dhanda, Adina Olaru, et al.
Epidemics|June 30, 2019
The contact structure of Great Britain's salmon and trout aquaculture industryA E Jones, L A Munro, D M Green, et al.
Alimentary Pharmacology & Therapeutics|October 2, 2023
In severe alcohol-related hepatitis, acute kidney injury is prevalent, associated with mortality independent of liver disease severity, and can be predicted using IL-8 and micro-RNAsLuke D Tyson, Stephen Atkinson, Robert W Hunter, et al.
Nature Communications|December 8, 2011
A complex multi-notch astronomical filter to suppress the bright infrared skyJ Bland-Hawthorn, S C Ellis, S G Leon-Saval, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 18, 2014
Lack of efficacy of an inhibitor of PDE4 in phase 1 and 2 trials of patients with nonalcoholic steatohepatitisVlad Ratziu, Pierre Bedossa, Sven M Francque, et al.
Frontline Gastroenterology|October 26, 2017
The impact of rifaximin-α on the hospital resource use associated with the management of patients with hepatic encephalopathy: a retrospective observational study (IMPRESS)Mark Hudson, Amr Radwan, Paola Di Maggio, et al.
Alimentary Pharmacology & Therapeutics|April 24, 2014
Review article: 2014 UK consensus guidelines - hepatitis C management and direct-acting anti-viral therapyM H Miller, K Agarwal, A Austin, et al.
Hepatology Communications|May 16, 2018
NI-0801, an anti-chemokine (C-X-C motif) ligand 10 antibody, in patients with primary biliary cholangitis and an incomplete response to ursodeoxycholic acidKathy L de Graaf, Geneviève Lapeyre, Florence Guilhot, et al.
Nature|May 29, 2020
A census of baryons in the Universe from localized fast radio burstsJ-P Macquart, J X Prochaska, M McQuinn, et al.
Hepatology Communications|April 7, 2023
Regulation of immune responses in primary biliary cholangitis: a transcriptomic analysis of peripheral immune cellsVictoria Mulcahy, Evaggelia Liaskou, Jose-Ezequiel Martin, et al.
Pageof 27